524640'un PE Oranı emsallerine kıyasla nasıldır?

Insufficient data to answer this question

524640'nin PE Oranı, IN Chemicals Sektöründeki diğer şirketlerle karşılaştırıldığında nasıldır?

Insufficient data to answer this question

524640'nin PE Oranı, Adil PE Oranına kıyasla nedir? Bu, şirketin tahmini kazanç büyümesini, kar marjlarını ve diğer risk faktörlerini dikkate alan beklenen PE Oranıdır.

Insufficient data to answer this question

Gelecekteki nakit akışlarına bakıldığında 524640 'un Adil Fiyatı nedir? Bu tahmin için İndirgenmiş Nakit Akışı modelini kullanıyoruz.

Insufficient data to answer this question

Analistin 12 aylık tahmini nedir ve konsensüs fiyat hedefine istatistiksel olarak güveniyor muyuz?

Insufficient data to answer this question

Archit Organosys (BSE:524640) - Hisse Senedi Fiyatı, Haberler ve Analizler

524640 Stoklara Genel Bakış

Archit Organosys Limited, Hindistan'da ve uluslararası alanda kimyasal ürünler üretmekte ve ticaretini yapmaktadır.

Şirket hakkında

524640 temel anali̇z
Kar Tanesi Skoru
Değerleme	0/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	1/6
Finansal Sağlık	5/6
Temettüler	0/6

Ödüller

Risk Analizi

Archit Organosys Limited Rakipler

Dhariwal

NSEI:DHARIWAL

₹1.3b

AVSL Industries

NSEI:AVSL

₹890.3m

Master Components

NSEI:MASTER

₹1.2b

Arabian Petroleum

NSEI:ARABIAN

₹967.2m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Archit Organosys
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	₹47.89
52 Haftanın En Yüksek Seviyesi	₹63.65
52 Haftanın En Düşük Seviyesi	₹35.10
Beta	0.19
11 Aylık Değişim	6.47%
3 Aylık Değişim	-3.06%
1 Yıllık Değişim	-5.97%
33 Yıllık Değişim	0.82%
5 Yıllık Değişim	394.22%
Halka arzdan bu yana değişim	23.43%

Son Haberler & Güncellemeler

Recent updates

Hissedar Getirileri

	524640	IN Chemicals	IN Pazar
7D	5.0%	2.3%	1.6%
1Y	-6.0%	22.7%	36.9%

Fiyat Oynaklığı

Is 524640's price volatile compared to industry and market?
524640 volatility
524640 Average Weekly Movement	5.1%
Chemicals Industry Average Movement	5.8%
Market Average Movement	6.2%
10% most volatile stocks in IN Market	9.3%
10% least volatile stocks in IN Market	4.0%

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1989	51	Kandarp Amin	www.architorg.com

Archit Organosys Limited Hindistan'da ve uluslararası alanda kimyasal ürünler üretmekte ve ticaretini yapmaktadır. Şirket, çeşitli tarım kimyasalları, kozmetik yüzey aktif maddeler, petrol sondaj kimyasalları, plastik katkı maddeleri vb. sentezinde kullanılan monokloroasetik asit ve sodyum monokloroasetat sunmaktadır.

Archit Organosys Limited Temel Bilgiler Özeti

Archit Organosys'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
524640 temel i̇stati̇sti̇kler
Piyasa değeri	₹982.74m
Kazançlar(TTM)	₹26.44m
Gelir(TTM)	₹1.09b

37.2x

F/K Oranı

0.9x

P/S Oranı

524640 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
524640 gelir tablosu (TTM)
Gelir	₹1.09b
Gelir Maliyeti	₹799.27m
Brüt Kâr	₹292.69m
Diğer Giderler	₹266.25m
Kazançlar	₹26.44m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

Nov 14, 2024

Hisse başına kazanç (EPS)	1.29
Brüt Marj	26.80%
Net Kâr Marjı	2.42%
Borç/Özkaynak Oranı	41.2%

524640 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

524640 Stoklara Genel Bakış

Ödüller

Risk Analizi

Archit Organosys Limited Rakipler

NSEI:DHARIWAL

₹1.3b

NSEI:AVSL

₹890.3m

NSEI:MASTER

₹1.2b

NSEI:ARABIAN

₹967.2m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer

Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.77 in 1Q 2024)

Recent updates

Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer

Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.77 in 1Q 2024)

Archit Organosys Limited to Report Q1, 2025 Results on Aug 08, 2024

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Investor sentiment improves as stock rises 25%

Full year 2024 earnings released: EPS: ₹1.60 (vs ₹5.53 in FY 2023)

New major risk - Market cap size

Archit Organosys Limited to Report Q4, 2024 Results on May 30, 2024

Investor sentiment improves as stock rises 18%

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Now 20% undervalued after recent price drop

New major risk - Market cap size

Third quarter 2024 earnings released: ₹0.22 loss per share (vs ₹1.09 profit in 3Q 2023)

New minor risk - Profit margin trend

Archit Organosys Limited Declares Dividend

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited to Report Q3, 2024 Results on Feb 14, 2024

Upcoming dividend of ₹0.50 per share at 1.0% yield

Archit Organosys Limited Proposes Declare

Archit Organosys Limited to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₹0.50 per share at 0.9% yield

Archit Organosys Limited, Annual General Meeting, Aug 22, 2023

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited Recommends a Final Dividend for the Financial Year Ended March 31, 2023

Chairman & Whole Time Director recently bought ₹507k worth of stock

Chairman & Whole Time Director recently bought ₹1.3m worth of stock

Investor sentiment deteriorated over the past week

Third quarter 2023 earnings released: EPS: ₹1.09 (vs ₹0.99 in 3Q 2022)

Archit Organosys Limited to Report Q3, 2023 Results on Jan 13, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Archit Organosys Limited to Report Q2, 2023 Results on Nov 11, 2022

Archit Organosys Limited Announces Chief Financial Officer Changes

Investor sentiment improved over the past week

Archit Organosys Limited Approves Dividend

Investor sentiment improved over the past week

Archit Organosys Limited, Annual General Meeting, Sep 08, 2022

First quarter 2023 earnings released: EPS: ₹2.01 (vs ₹1.42 in 1Q 2022)

Archit Organosys Limited to Report Q1, 2023 Results on Jul 25, 2022

Archit Organosys Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Archit Organosys Limited Announces Appointment of Vijay A. Boliya as Company Secretary and Compliance Officer, Effective March 1, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Archit Organosys Limited Announces Resignation of Anchal Bansal as Company Secretary and Compliance Officer

Second quarter 2022 earnings released: EPS ₹0.68 (vs ₹0.70 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹1.42 (vs ₹0.55 in 1Q 2021)

Independent Director Rajendraprasad Shah has left the company

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹3.33 (vs ₹0.53 loss in FY 2020)

Investor sentiment improved over the past week